13.3  -0.4 (-2.92%)		01-16 15:59
Open: 13.5 High: 13.705 Volume: 7,993		Pre. Close: 13.7 Low: 13.15 Market Cap: 66(M)

Short term
Mid term
Targets	6-month :	16	1-year :	17.23
Resists	First :	13.7	Second :	14.76
Pivot price	14.06
Supports	First :	12	Second :	9.98
MAs	MA(5) :	13.71	MA(20) :	13.8
	MA(100) :	12.79	MA(250) :	10.22
MACD	MACD :	0.1	Signal :	0.2
%K %D	K(14,3) :	36.2	D(3) :	52.4
RSI	RSI(14): 46.3
52-week	High :	14.76	Low :	6.55

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ DXR ] has closed above bottom band by 4.1%. Bollinger Bands are 9.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	13.72 - 13.79	13.79 - 13.85
Low:	12.96 - 13.04	13.04 - 13.12
Close:	13.15 - 13.28	13.28 - 13.41

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Fri, 16 Jan 2026
Price-Driven Insight from (DXR) for Rule-Based Strategy - Stock Traders Daily

Wed, 07 Jan 2026
Daxor (NYSEAMERICAN:DXR) Shares Cross Above Fifty Day Moving Average – Here’s What Happened - Defense World

Mon, 05 Jan 2026
(DXR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Thu, 25 Dec 2025
Precision Trading with Daxor Corporation (DXR) Risk Zones - Stock Traders Daily

Thu, 11 Dec 2025
Feldschuh buys 18,000 Daxor shares worth $0 - Investing.com

Tue, 21 Oct 2025
Daxor Corporation to Participate in Exclusive Maxim Growth Summit Featuring 40 Promising Healthcare Companies - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	4.98e+006 (%)
Held by Institutions	2.12e+006 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	66310
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.15
Profit Margin	2 %
Operating Margin	710.8 %
Return on Assets (ttm)	-1 %
Return on Equity (ttm)	509.4 %
Qtrly Rev. Growth	5.2 %
Gross Profit (p.s.)	0.31
Sales Per Share	-0.01
EBITDA (p.s.)	-0.01
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	83.12
Price to Sales	-1.10083e+006
Price to Cash Flow	0

Dividend	3170
Forward Dividend	6040
Dividend Yield	23834.5%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.